This inventor holds 1 USPTO granted patent. Top assignee: Universitaet Des Saarlandes. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Erika Ziegler: Innovator in Hormone-Related Disease Treatment
Introduction
Erika Ziegler is a prominent inventor based in Voelklingen, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of hormone-related diseases. Her innovative work focuses on developing non-steroidal inhibitors that target specific enzymes involved in hormone regulation.
Latest Patents
Erika Ziegler holds a patent for "17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases." This invention pertains to the use of these inhibitors for the treatment and prevention of hormone-dependent diseases, especially those that are estrogen-dependent. The patent also details suitable inhibitors and methods for their production. She has 1 patent to her name.
Career Highlights
Ziegler is affiliated with the University of Saarland, where she conducts her research and development work. Her academic background and research initiatives have positioned her as a key figure in her field.
Collaborations
Throughout her career, Erika has collaborated with notable colleagues, including Rolf Wolfgang Hartmann and Martin Frotscher. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.
Conclusion
Erika Ziegler's work in developing inhibitors for hormone-related diseases showcases her dedication to medical innovation. Her contributions are vital in the ongoing fight against hormone-dependent conditions, and her research continues to pave the way for future advancements in this area.